Suppr超能文献

抗血栓药物体外有效性的比较研究

Comparative study on the in vitro effectiveness of antithrombotic agents.

作者信息

Pâques E P, Römisch J

机构信息

Research Laboratories of Behringwerke AG, Marburg, FRG.

出版信息

Thromb Res. 1991 Oct 1;64(1):11-21. doi: 10.1016/0049-3848(91)90201-7.

Abstract

The synthetic low molecular weight inhibitors MD 805, FUT-175 and FOY as well as heparin and r-Hirudin were compared for their in vitro antithrombotic potencies and protease specificities. The amidolytic activity of thrombin and the plasma coagulation were effectively inhibited by MD 805 and, in particular, by r-Hirudin. FUT-175 and FOY revealed only weak inhibition. None of the synthetic substances discriminated between alpha-, beta- and gamma-thrombin. Beside r-Hirudin only MD 805 revealed a relatively good specificity for thrombin. On the contrary, FUT-175 and FOY are unspecific and can not be classified as thrombin inhibitors.

摘要

比较了合成的低分子量抑制剂MD 805、FUT - 175和FOY以及肝素和重组水蛭素的体外抗血栓形成能力和蛋白酶特异性。MD 805,尤其是重组水蛭素可有效抑制凝血酶的酰胺水解活性和血浆凝固。FUT - 175和FOY仅表现出微弱的抑制作用。这些合成物质均不能区分α-、β-和γ-凝血酶。除重组水蛭素外,只有MD 805对凝血酶表现出相对较好的特异性。相反,FUT - 175和FOY是非特异性的,不能归类为凝血酶抑制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验